Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Debt / NOTE 1.500% 9/1
-
Unit price / market price
-
$0.9188
-
Total 13F principal
-
$287,509,503
-
Principal change
-
+$8,857,231
-
Total reported value
-
$273,105,852
-
Number of holders
-
14
-
Value change
-
+$15,160,001
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of PTC THERAPEUTICS INC - NOTE 1.500% 9/1 as of Q4 2023
As of 31 Dec 2023 PTC THERAPEUTICS INC - NOTE 1.500% 9/1 had 14 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $287,509,503 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included FRANKLIN RESOURCES INC, STEELHEAD PARTNERS LLC, D. E. Shaw & Co., Inc., WOLVERINE ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, Context Capital Management, LLC, LINDEN ADVISORS LP, WHITEBOX ADVISORS LLC, AMERIPRISE FINANCIAL INC, and READYSTATE ASSET MANAGEMENT LP.
This table shows 14 bond principal holders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.